Semaglutide
STEP 2
Novo Nordisk · Phase 3 · Completed · Enrollment 1210
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide 1.0 mg | Obesity or overweight | 1.0 mg | 4 | ITT | n/r |
| Semaglutide 2.4 mg | Obesity or overweight | 2.4 mg | 4 | ITT | n/r |
| Semaglutide placebo I/II | Obesity or overweight | n/r | 4 | ITT | n/r |